Attention-Deficit Hyperactivity Disorder Market Forecast

Datamonitor
July 3, 2009
119 Pages - SKU: DFMN2303358
License type:
Table of Contents Related Reports
Introduction

Driven primarily by continued uptake of Shire's market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. Ongoing uptake of Shire's Vyvanse (lisdexamfetamine), was also a key contributor to market growth between 2007 and 2008.

Reasons to Purchase
  • This report gives a strategic analysis of the likely impact that recent events will have on the future ADHD market.
  • Includes sales forecasts for the key ADHD brands and generics as well as pipeline agents in the seven major markets to 2018.
  • Quantify the current and future size of the seven major ADHD markets.
Please note: this is delivered as a Zip file.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Behavioral Health Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!